Sharp Therapeutics Corp. (TSXV:SHRX)
2.600
-0.750 (-22.39%)
At close: Dec 5, 2025
| Market Cap | 78.20M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.63M |
| Shares Out | 30.08M |
| EPS (ttm) | -0.15 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,700 |
| Average Volume | 3,723 |
| Open | 2.600 |
| Previous Close | 3.350 |
| Day's Range | 2.600 - 2.600 |
| 52-Week Range | 0.230 - 5.000 |
| Beta | -1.47 |
| RSI | 47.13 |
| Earnings Date | Nov 28, 2025 |